Introduction: The association between blood pressure (BP) and incidence of Parkinson’s disease (PD) in older adults remains uncertain. Therefore, this study aimed to investigate the association between BP (high or low) and PD incidence in adults aged ≥75 years. Methods: In this nationwide population-based cohort study, we enrolled participants aged ≥75 years without a prior PD diagnosis who had undergone health examination provided by the Korean National Health Insurance Service at least once from January 1, 2009, to December 31, 2012. The participants were followed up until December 31, 2019, or the date of their death. The Cox proportional hazards model was used to assess the risk of PD depending on systolic BP (SBP), diastolic BP (DBP), and pulse pressure. Results: Overall, 963,525 participants were enrolled in the analysis and followed up until December 31, 2019, or the date of death (40.7% male, mean age 78.5 ± 3.6 years). The mean SBP and DBP were 131.4 ± 16.7 and 77.9 ± 10.3 mm Hg, respectively. During the 10-year follow-up period, 16,414 (1.7%) newly diagnosed cases of PD were reported. A significant inverse dose-response association was found between SBP and PD incidence. In the subgroup analysis, this association was maintained for most variables, including sex, use of antihypertensive medication, comorbidities, alcohol consumption, physical activity, and body mass index, except for smoking status. Conclusion: Lower SBP and DBP were associated with a higher PD incidence in older adults. These results may have substantial implications for determining the optimal BP control target in adults aged ≥75 years.

1.
Pringsheim
T
,
Jette
N
,
Frolkis
A
,
Steeves
TD
.
The prevalence of Parkinson’s disease: a systematic review and meta-analysis
.
Mov Disord
.
2014 Nov
29
13
1583
90
.
2.
GBD 2016 Parkinson’s Disease Collaborators
.
Global, regional, and national burden of Parkinson’s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
.
Lancet Neurol
.
2018 Nov
17
11
939
53
.
3.
Postuma
RB
,
Berg
D
,
Stern
M
,
Poewe
W
,
Olanow
CW
,
Oertel
W
.
MDS clinical diagnostic criteria for Parkinson’s disease
.
Mov Disord
.
2015 Oct
30
12
1591
601
.
4.
Sung
VW
,
Nicholas
AP
.
Nonmotor symptoms in Parkinson’s disease: expanding the view of Parkinson’s disease beyond a pure motor, pure dopaminergic problem
.
Neurol Clin
.
2013 Aug
31
3 Suppl
S1
16
.
5.
Milazzo
V
,
Di Stefano
C
,
Vallelonga
F
,
Sobrero
G
,
Zibetti
M
,
Romagnolo
A
.
Reverse blood pressure dipping as marker of dysautonomia in Parkinson disease
.
Parkinsonism Relat Disord
.
2018 Nov
56
82
7
.
6.
Hiorth
YH
,
Pedersen
KF
,
Dalen
I
,
Tysnes
OB
,
Alves
G
.
Orthostatic hypotension in Parkinson disease: a 7-year prospective population-based study
.
Neurology
.
2019 Oct 15
93
16
e1526
34
.
7.
Qiu
C
,
Hu
G
,
Kivipelto
M
,
Laatikainen
T
,
Antikainen
R
,
Fratiglioni
L
.
Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study
.
Hypertension
.
2011 Jun
57
6
1094
100
.
8.
Lai
SW
,
Liao
KF
,
Lin
CL
,
Lin
CC
,
Sung
FC
.
Hearing loss may be a non-motor feature of Parkinson’s disease in older people in Taiwan
.
Eur J Neurol
.
2014 May
21
5
752
7
.
9.
Lai
SW
,
Lin
CL
,
Liao
KF
,
Chang-Ou
KC
.
Increased risk of Parkinson’s disease in cataract patients: a population-based cohort study
.
Parkinsonism Relat Disord
.
2015 Jan
21
1
68
71
.
10.
Lin
JC
,
Lin
CS
,
Hsu
CW
,
Lin
CL
,
Kao
CH
.
Association between Parkinson’s disease and inflammatory bowel disease: a nationwide Taiwanese retrospective cohort study
.
Inflamm Bowel Dis
.
2016 May
22
5
1049
55
.
11.
Hou
L
,
Li
Q
,
Jiang
L
,
Qiu
H
,
Geng
C
,
Hong
JS
.
Hypertension and diagnosis of Parkinson’s disease: a meta-analysis of cohort studies
.
Front Neurol
.
2018
;
9
:
162
.
12.
Chen
J
,
Zhang
C
,
Wu
Y
,
Zhang
D
.
Association between hypertension and the risk of Parkinson’s disease: a meta-analysis of analytical studies
.
Neuroepidemiology
.
2019
52
3–4
181
92
.
13.
Yoo
SW
,
Kim
JS
,
Oh
YS
,
Ryu
DW
,
Ha
S
,
Yoo
JY
.
Cardiac sympathetic burden reflects Parkinson disease burden, regardless of high or low orthostatic blood pressure changes
.
NPJ Parkinsons Dis
.
2021 Aug 12
7
1
71
.
14.
McCann
SJ
,
LeCouteur
DG
,
Green
AC
,
Brayne
C
,
Johnson
AG
,
Chan
D
.
The epidemiology of Parkinson’s disease in an Australian population
.
Neuroepidemiology
.
1998
;
17
(
6
):
310
7
.
15.
Herishanu
YO
,
Medvedovski
M
,
Goldsmith
JR
,
Kordysh
E
.
A case-control study of Parkinson’s disease in urban population of southern Israel
.
Can J Neurol Sci
.
2001 May
28
2
144
7
.
16.
Miyake
Y
,
Tanaka
K
,
Fukushima
W
,
Sasaki
S
,
Kiyohara
C
,
Tsuboi
Y
.
Case-control study of risk of Parkinson’s disease in relation to hypertension, hypercholesterolemia, and diabetes in Japan
.
J Neurol Sci
.
2010 Jun 15
293
1–2
82
6
.
17.
Simon
KC
,
Chen
H
,
Schwarzschild
M
,
Ascherio
A
.
Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
.
Neurology
.
2007 Oct 23
69
17
1688
95
.
18.
Cereda
E
,
Cassani
E
,
Barichella
M
,
Spadafranca
A
,
Caccialanza
R
,
Bertoli
S
.
Low cardiometabolic risk in Parkinson’s disease is independent of nutritional status, body composition and fat distribution
.
Clin Nutr
.
2012 Oct
31
5
699
704
.
19.
Kjeldsen
S
,
Feldman
RD
,
Lisheng
L
,
Mourad
JJ
,
Chiang
CE
,
Zhang
W
.
Updated national and international hypertension guidelines: a review of current recommendations
.
Drugs
.
2014 Nov
74
17
2033
51
.
20.
Oliveros
E
,
Patel
H
,
Kyung
S
,
Fugar
S
,
Goldberg
A
,
Madan
N
.
Hypertension in older adults: assessment, management, and challenges
.
Clin Cardiol
.
2020 Feb
43
2
99
107
.
21.
Ng
YF
,
Ng
E
,
Lim
EW
,
Prakash
KM
,
Tan
LCS
,
Tan
EK
.
Case-control study of hypertension and Parkinson’s disease
.
NPJ Parkinsons Dis
.
2021 Jul 21
7
1
63
.
22.
Lionakis
N
,
Mendrinos
D
,
Sanidas
E
,
Favatas
G
,
Georgopoulou
M
.
Hypertension in the elderly
.
World J Cardiol
.
2012 May 26
4
5
135
47
.
23.
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group
.
Jama
.
1991 Jun 26
265
24
3255
64
.
24.
Staessen
JA
,
Fagard
R
,
Thijs
L
,
Celis
H
,
Arabidze
GG
,
Birkenhäger
WH
.
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators
.
Lancet
.
1997
;
350
(
9080
):
757
64
.
25.
Beckett
NS
,
Peters
R
,
Fletcher
AE
,
Staessen
JA
,
Liu
L
,
Dumitrascu
D
.
Treatment of hypertension in patients 80 years of age or older
.
N Engl J Med
.
2008 May 1
358
18
1887
98
.
26.
Williamson
JD
,
Supiano
MA
,
Applegate
WB
,
Berlowitz
DR
,
Campbell
RC
,
Chertow
GM
.
Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 Years: a randomized clinical trial
.
JAMA
.
2016 Jun 28
315
24
2673
82
.
27.
Powers
KM
,
Smith-Weller
T
,
Franklin
GM
,
Longstreth
WT
Jr
,
Swanson
PD
,
Checkoway
H
.
Diabetes, smoking, and other medical conditions in relation to Parkinson’s disease risk
.
Parkinsonism Relat Disord
.
2006 Apr
12
3
185
9
.
28.
Boshuizen
HC
,
Izaks
GJ
,
van Buuren
S
,
Ligthart
GJ
.
Blood pressure and mortality in elderly people aged 85 and older: community based study
.
BMJ
.
1998 Jun 13
316
7147
1780
4
.
29.
Verghese
J
,
Lipton
RB
,
Hall
CB
,
Kuslansky
G
,
Katz
MJ
.
Low blood pressure and the risk of dementia in very old individuals
.
Neurology
.
2003 Dec 23
61
12
1667
72
.
30.
Mancia
G
,
Fagard
R
,
Narkiewicz
K
,
Redon
J
,
Zanchetti
A
,
Böhm
M
.
2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC)
.
Eur Heart J
.
2013 Jul
34
28
2159
219
.
31.
Hernán
MA
,
Takkouche
B
,
Caamaño-Isorna
F
,
Gestal-Otero
JJ
.
A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson’s disease
.
Ann Neurol
.
2002 Sep
52
3
276
84
.
32.
de Lau
LM
,
Breteler
MM
.
Epidemiology of Parkinson’s disease
.
Lancet Neurol
.
2006 Jun
5
6
525
35
.
33.
Wirdefeldt
K
,
Adami
HO
,
Cole
P
,
Trichopoulos
D
,
Mandel
J
.
Epidemiology and etiology of Parkinson’s disease: a review of the evidence
.
Eur J Epidemiol
.
2011 Jun
26
Suppl 1
S1
58
.
34.
Becker
C
,
Jick
SS
,
Meier
CR
.
Use of antihypertensives and the risk of Parkinson disease
.
Neurology
.
2008 Apr 15
70
Issue 16, Part 2
1438
44
.
35.
Espay
AJ
,
Marsili
L
,
Mahajan
A
,
Sturchio
A
,
Pathan
R
,
Pilotto
A
.
Rivastigmine in Parkinson’s disease dementia with orthostatic hypotension
.
Ann Neurol
.
2021 Jan
89
1
91
8
.
36.
Marsili
L
,
Duque
KR
,
Sturchio
A
,
Sobrero
G
,
Premoli
I
,
Dwivedi
AK
.
Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotension
.
Parkinsonism Relat Disord
.
2022 Jun
99
62
4
.
37.
1993 Guidelines for the Management of Mild Hypertension
.
Memorandum from a World health organization/international society of hypertension meeting. Guidelines subcommittee of the WHO/ISH mild hypertension liaison committee
.
Hypertension
.
1993 Sep
22
3
392
403
.
38.
Krzesiński
P
,
Stańczyk
A
,
Gielerak
G
,
Piotrowicz
K
,
Banak
M
,
Wójcik
A
.
The diagnostic value of supine blood pressure in hypertension
.
Arch Med Sci
.
2016 Apr 1
2
2
310
8
.
You do not currently have access to this content.